
Epetōme
a daily pre + probiotic with 11 clinically trialled bacterial strains alongside FOS fibre, vitamin D, zinc and biotin. Duo cap® technology ensures targeted delivery within the gut. Just once a day, every day.
Epetōme has no funding amount on record yet; its latest known round is Seed (Feb 2026). Recent Funding first saw it on October 2, 2026.
Raise history
- Seed · amount undisclosedSource: crunchbase.com
Related other companies
WWedding WeekenderOct 1, 2026
RR2CreteOct 1, 2026
AAdaptCloseSep 30, 2026
EElredo VoiceSep 29, 2026
FFIG LivingSep 29, 2026
PPakajoSep 29, 2026
NNovuxSep 29, 2026
MMurrmurSep 29, 2026
Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/epetome.